Enhanced Metabolic Syndrome Management Through Cannabidiol-Loaded PLGA Nanoparticles: Development and In Vitro Evaluation.
Saved in:
| Title: | Enhanced Metabolic Syndrome Management Through Cannabidiol-Loaded PLGA Nanoparticles: Development and In Vitro Evaluation. |
|---|---|
| Authors: | El-Hammadi MM; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain., Martín-Navarro L; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain., Berrocoso E; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain.; Neuropsychopharmacology & Psychobiology Research Group, Department of Psychology, University of Cadiz, Cádiz, Spain.; Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, University of Cádiz, Cádiz, Spain., Álvarez-Fuentes J; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain.; Instituto de Biomedicina de Sevilla (IBIS)-Campus Hospital Universitario Virgen del Rocío, Sevilla, Spain., Crespo-Facorro B; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain.; Instituto de Biomedicina de Sevilla (IBIS)-Campus Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocio, Sevilla, Spain., Suárez-Pereira I; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain.; Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, University of Cádiz, Cádiz, Spain.; Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, University of Cadiz, Cádiz, Spain., Vázquez-Bourgon J; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain.; Department of Psychiatry, University Hospital Marqués de Valdecilla. Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain.; Departamento de Medicina y Psiquiatría, Universidad de Cantabria, Santander, Spain., Martín-Banderas L; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain.; Instituto de Biomedicina de Sevilla (IBIS)-Campus Hospital Universitario Virgen del Rocío, Sevilla, Spain. |
| Source: | Journal of biomedical materials research. Part A [J Biomed Mater Res A] 2025 May; Vol. 113 (5), pp. e37916. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101234237 Publication Model: Print Cited Medium: Internet ISSN: 1552-4965 (Electronic) Linking ISSN: 15493296 NLM ISO Abbreviation: J Biomed Mater Res A Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40277882 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enhanced Metabolic Syndrome Management Through Cannabidiol-Loaded PLGA Nanoparticles: Development and In Vitro Evaluation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22El-Hammadi+MM%22">El-Hammadi MM</searchLink>; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Martín-Navarro+L%22">Martín-Navarro L</searchLink>; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Berrocoso+E%22">Berrocoso E</searchLink>; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain.; Neuropsychopharmacology & Psychobiology Research Group, Department of Psychology, University of Cadiz, Cádiz, Spain.; Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, University of Cádiz, Cádiz, Spain.<br /><searchLink fieldCode="AU" term="%22Álvarez-Fuentes+J%22">Álvarez-Fuentes J</searchLink>; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain.; Instituto de Biomedicina de Sevilla (IBIS)-Campus Hospital Universitario Virgen del Rocío, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Crespo-Facorro+B%22">Crespo-Facorro B</searchLink>; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain.; Instituto de Biomedicina de Sevilla (IBIS)-Campus Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocio, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Suárez-Pereira+I%22">Suárez-Pereira I</searchLink>; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain.; Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, University of Cádiz, Cádiz, Spain.; Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, University of Cadiz, Cádiz, Spain.<br /><searchLink fieldCode="AU" term="%22Vázquez-Bourgon+J%22">Vázquez-Bourgon J</searchLink>; Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain.; Department of Psychiatry, University Hospital Marqués de Valdecilla. Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain.; Departamento de Medicina y Psiquiatría, Universidad de Cantabria, Santander, Spain.<br /><searchLink fieldCode="AU" term="%22Martín-Banderas+L%22">Martín-Banderas L</searchLink>; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain.; Instituto de Biomedicina de Sevilla (IBIS)-Campus Hospital Universitario Virgen del Rocío, Sevilla, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101234237%22">Journal of biomedical materials research. Part A</searchLink> [J Biomed Mater Res A] 2025 May; Vol. 113 (5), pp. e37916. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%22">John Wiley & Sons </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101234237 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-4965 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215493296%22">15493296 </searchLink><i>NLM ISO Abbreviation: </i>J Biomed Mater Res A <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40277882 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/jbm.a.37916 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e37916 Titles: – TitleFull: Enhanced Metabolic Syndrome Management Through Cannabidiol-Loaded PLGA Nanoparticles: Development and In Vitro Evaluation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: El-Hammadi MM – PersonEntity: Name: NameFull: Martín-Navarro L – PersonEntity: Name: NameFull: Berrocoso E – PersonEntity: Name: NameFull: Álvarez-Fuentes J – PersonEntity: Name: NameFull: Crespo-Facorro B – PersonEntity: Name: NameFull: Suárez-Pereira I – PersonEntity: Name: NameFull: Vázquez-Bourgon J – PersonEntity: Name: NameFull: Martín-Banderas L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2025 May Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1552-4965 Numbering: – Type: volume Value: 113 – Type: issue Value: 5 Titles: – TitleFull: Journal of biomedical materials research. Part A Type: main |
| ResultId | 1 |